ClinPhone, one of the world's largest clinical technology organisations has teamed up with a leading US expert in adaptive clinical trials (ACT) to deliver a complete service solution to the pharmaceutical industry.
The new partnership with Cytel Inc., offers sponsors the combined expertise of the two organisations in successful design, planning and implementation of adaptive and other complex study designs.
ClinPhone-Cytel adaptive trial solutions are tailored to the requirements and objectives of each individual clinical development programme. This integrated service provides all the essential components for adaptive trial planning and implementation, including study design consulting, trial simulations, supplies planning and management, clinical data collection, randomisation, trial supply management, data analysis and reporting.
ACTs refer to clinical studies that use accumulating response data to optimise pre-determined aspects of the study design without undermining the validity and integrity of the trial. By making mid-course adjustments to the trial, adaptive trials increase the ability to answer the study's key research objectives, and improve the likelihood of a successful outcome. ClinPhone-Cytel solutions combine the innovative statistical techniques and trial technology advances that make designing and conducting adaptive trials practical for sponsor organizations of all sizes.
Irving Dark, Cytel's vice president of clinical research services, said: "The ClinPhone-Cytel collaboration provides sponsors with the full-service offering needed for successful Adaptive Clinical Trials. This partnership underscores our commitment to be the leader in innovative trial design and implementation services."
Dr. Bill Byrom, vice president of product strategy and marketing of ClinPhone, said: "Technology plays a central role in delivering these types of studies, and Cytel and ClinPhone together are leading the way in offering integrated services that provide a comprehensive solution for the sponsor wishing to benefit from the power of adaptive trials."
ClinPhone is based in Nottingham, UK and Cytel is based in Cambridge, USA.